RACHEL DELANEY: Open Payments
NPI 1407325772 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,523 in 67 payments from 23 companies in 2025. Trend: 2023 $1,814 · 2024 $2,163 · 2025 $2,523
Food & beverage: $2,523
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $358 |
| Insmed, Inc. | 2 | $233 |
| Alnylam Pharmaceuticals Inc. | 5 | $209 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $202 |
| Novo Nordisk Inc | 5 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $171 |
| Surmodics, Inc. | 2 | $157 |
| Xeris Pharmaceuticals, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Kestra Medical Technology Services, Inc. | 1 | $106 |
Products named: SAPIEN 3 Ultra RESILIA, Arikayce, LifeVest, JARDIANCE, AMVUTTRA, Sublime 014 Rx PTA Balloon Dilatation Catheter, GVOKE HYPOPEN, Ozempic.
Industry payments across OK — which companies pay providers there.
